ArticleDrugs in R&D2022

Impact of Renal Function on Anti-factor Xa Activity Concentrations with Edoxaban Use in Patients with Non-valvular Atrial Fibrillation.

Ryohei Ono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.